Independent Advisor Alliance Penumbra Inc Transaction History

Independent Advisor Alliance

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$181.44 - $260.22 $12,337 - $17,694	-68 Reduced 7.51%	838 $210,000
Q3 2023 Oct 24, 2023	SELL	$240.69 - $338.77 $10,831 - $15,244	-45 Reduced 4.73%	906 $219,000
Q2 2023 Jul 28, 2023	SELL	$271.54 - $344.06 $14,663 - $18,579	-54 Reduced 5.37%	951 $327,000
Q1 2023 May 12, 2023	BUY	$220.43 - $278.69 $221,532 - $280,083	1,005 New	1,005 $280,000
Q3 2022 Nov 04, 2022	BUY	$120.36 - $205.88 $136,006 - $232,644	1,130 New	1,130 $214,000

374

29.2M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.25B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

Stay updated on Independent Advisor Alliance with notifications on news.